Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Immunological crossroads: The intriguing dance between hepatitis C and autoimmune hepatitis.
Soldera J World J Hepatol. 2024; 16(6):867-870.
PMID: 38948443 PMC: 11212656. DOI: 10.4254/wjh.v16.i6.867.
Choi C, Botros Y, Shah J, Xue P, Jones A, Galan M J Clin Transl Hepatol. 2021; 8(4):459-462.
PMID: 33447530 PMC: 7782114. DOI: 10.14218/JCTH.2020.00062.
References
1.
Giannini E, Basso M, Savarino V, Picciotto A
. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther. 2009; 31(4):502-8.
DOI: 10.1111/j.1365-2036.2009.04201.x.
View
2.
Stewart R, MacDonald B, Chu T, Moore J, Fasanmi E, Ojha R
. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population. Dig Dis Sci. 2018; 63(12):3233-3240.
PMC: 6244975.
DOI: 10.1007/s10620-018-5205-2.
View
3.
Matsumoto K, Kikuchi K, Kajiyama Y, Takano Y, Mabuchi M, Doi S
. Development of Autoimmune Hepatitis during Direct-acting Antiviral Therapy for Chronic Hepatitis C Virus Infection. Intern Med. 2018; 57(18):2669-2673.
PMC: 6191578.
DOI: 10.2169/internalmedicine.0613-17.
View
4.
Czaja A
. Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management. Dig Dis Sci. 2018; 63(7):1706-1725.
DOI: 10.1007/s10620-018-5072-x.
View
5.
Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N
. Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir. Case Rep Gastroenterol. 2017; 11(2):305-311.
PMC: 5471785.
DOI: 10.1159/000475752.
View